Company Profile
Applied Molecular Transport Stock Price, News & Analysis
- Ticker:
- AMTI
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Why the stock is moving
Current closing-price context is not available for AMTI.
Company overview
Business overview
Applied Molecular Transport was a biotechnology company focused on oral delivery of biologics and peptides before becoming a historical ticker. Its core premise was that better delivery could unlock new uses for difficult-to-administer molecules.
Geographic Base and Sector Classification
Applied Molecular Transport was headquartered in the United States and traded on NASDAQ. It sat in drug-delivery biotechnology.
Business Model Characteristics
The business depended on platform validation, clinical milestones, and the ability to prove oral delivery could change the treatment landscape. Investors watched early data and partnership or financing developments.
Position Within the Biotechnology Landscape
Applied Molecular Transport occupied a platform-delivery niche within biotech. The stock was driven by whether its oral transport technology could create a durable therapeutic edge.
Future catalysts
Applied Molecular Transport is now a legacy and closeout story, so the catalysts are any strategic or asset-resolution update rather than a fresh development milestone. The market is mainly focused on residual value.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does Applied Molecular Transport do?
Applied Molecular Transport was a biotechnology company focused on oral delivery of biologics and peptides before becoming a historical ticker. Its core premise was that better delivery could unlock new uses for difficult-to-administer molecules.
On which exchange is AMTI stock listed?
Applied Molecular Transport (AMTI) is associated with NASDAQ, United States, Biopharma.
What is Applied?
Applied Molecular Transport is now a legacy and closeout story, so the catalysts are any strategic or asset-resolution update rather than a fresh development milestone.
Which conditions is Applied Molecular Transport targeting with Applied?
Applied Molecular Transport is now a legacy and closeout story, so the catalysts are any strategic or asset-resolution update rather than a fresh development milestone.
How does Applied Molecular Transport describe recent progress with Applied?
Applied Molecular Transport is now a legacy and closeout story, so the catalysts are any strategic or asset-resolution update rather than a fresh development milestone.
What is Molecular?
Applied Molecular Transport was a biotechnology company focused on oral delivery of biologics and peptides before becoming a historical ticker.
What should investors watch for with Molecular?
Applied Molecular Transport is now a legacy and closeout story, so the catalysts are any strategic or asset-resolution update rather than a fresh development milestone.
What is Transport?
Applied Molecular Transport was a biotechnology company focused on oral delivery of biologics and peptides before becoming a historical ticker.